We are live on ! Find out more
FO

FT Options Portfolio holdings

AUM $66.4M
1-Year Est. Return 18.48%
This Fund
S&P 500
This Quarter Est. Return
+2.11%
1 Year Est. Return
+18.48%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$66.4M
AUM Growth
+$8.29M
Cap. Flow
+$122M
Cap. Flow %
183.83%
Top 10 Hldgs %
32.21%
Holding
297
New
108
Increased
49
Reduced
51
Closed
72

Top Buys

Rank Stock Value
1
INCY icon
Incyte
INCY
+$3.53M
2
TEVA icon
Teva Pharmaceuticals
TEVA
+$2.94M
3
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
+$2.18M
4
ARAV
Aravive, Inc. Common Stock
ARAV
+$1.54M
5
SIOX
Sio Gene Therapies Inc. Common Stock
SIOX
+$1.37M

Top Sells

Rank Stock Value
1
GIS icon
General Mills
GIS
+$2.52M
2
PTLA
Portola Pharmaceuticals, Inc.
PTLA
+$2.31M
3
AMGN icon
Amgen
AMGN
+$2.08M
4
ABT icon
Abbott
ABT
+$1.72M
5
CLVS
Clovis Oncology, Inc.
CLVS
+$1.56M

Sector Composition

Rank Sector Weight
1 Healthcare 41.81%
2 Consumer Discretionary 7.1%
3 Consumer Staples 6.25%
4 Communication Services 0.99%
5 Materials 0.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
REGN icon
151
CALL
Regeneron Pharmaceuticals
REGN
$70.9B
$29K 0.04%
7,500
+2,500
+50% +$1.19M
HAIN icon
152
CALL
Hain Celestial
HAIN
$50.6M
$28K 0.04%
10,000
+4,100
+69% +$169K
HSY icon
153
PUT
Hershey
HSY
$34.8B
$28K 0.04%
6,800
– –
AVXS
154
PUT
DELISTED
AveXis, Inc. Common Stock
AVXS
$28K 0.04%
+15,000
New +$1.35M
CLX icon
155
PUT
Clorox
CLX
$11.6B
$26K 0.04%
5,500
-30,100
-85% -$4.04M
K
156
PUT
DELISTED
Kellanova
K
$26K 0.04%
5,325
-20,342
-79% -$1.28M
PTCT icon
157
PUT
PTC Therapeutics
PTCT
$6.52B
$25K 0.04%
+25,000
New +$489K
ALNY icon
158
PUT
Alnylam Pharmaceuticals
ALNY
$35.7B
$24K 0.04%
38,700
+18,700
+94% +$1.6M
JUNO
159
CALL
DELISTED
Juno Therapeutics, Inc.
JUNO
$24K 0.04%
+12,300
New +$419K
EXAS
160
PUT
DELISTED
Exact Sciences
EXAS
$23K 0.03%
+7,000
New +$282K
BHC icon
161
PUT
Bausch Health
BHC
$1.8B
$22K 0.03%
25,500
-9,500
-27% -$144K
EXAS
162
CALL
DELISTED
Exact Sciences
EXAS
$22K 0.03%
+7,000
New +$282K
PLCE icon
163
CALL
Children's Place
PLCE
$65.8M
$22K 0.03%
+11,400
New +$1.23M
LOXO
164
PUT
DELISTED
Loxo Oncology, Inc
LOXO
$22K 0.03%
+3,000
New +$233K
BHC icon
165
CALL
Bausch Health
BHC
$1.8B
$20K 0.03%
25,500
-14,100
-36% -$213K
IBB icon
166
CALL
iShares Biotechnology ETF
IBB
$9.23B
$20K 0.03%
12,000
-33,000
-73% -$3.53M
MOS icon
167
The Mosaic Company
MOS
$7.03B
$20K 0.03%
+933
New +$20.2K
ARAV
168
CALL
DELISTED
Aravive, Inc. Common Stock
ARAV
$19K 0.03%
+56,183
New +$5.67M
GDX icon
169
PUT
VanEck Gold Miners ETF
GDX
$21.8B
$18K 0.03%
+6,000
New +$139K
QSR icon
170
PUT
Restaurant Brands International
QSR
$26B
$18K 0.03%
+10,000
New +$618K
ALXN
171
CALL
DELISTED
Alexion Pharmaceuticals
ALXN
$18K 0.03%
+2,500
New +$340K
PF
172
CALL
DELISTED
Pinnacle Foods, Inc.
PF
$18K 0.03%
26,700
+7,000
+36% +$415K
AERI
173
CALL
DELISTED
Aerie Pharmaceuticals
AERI
$17K 0.03%
+16,000
New +$873K
AER icon
174
CALL
AerCap
AER
$23.2B
$16K 0.02%
+10,000
New +$490K
CYTK icon
175
PUT
Cytokinetics
CYTK
$10.9B
$15K 0.02%
+5,000
New +$68.3K
5 6
7
8 9

Similar funds

MC
Micawber Capital Seattle, Washington $62.9M AUM 20.32% 1-Year Est. Return
FIM
Friedberg Investment Management Houston, Texas $61.9M AUM 20.07% 1-Year Est. Return
TLIC
Thai Life Insurance Company Bangkok, Thailand $71M AUM 20.14% 1-Year Est. Return
MKCM
Mount Kellett Capital Management New York $61M AUM 12.22% 1-Year Est. Return
ACM
Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return
MFM
Marianas Fund Management New York $58.1M AUM 10.84% 1-Year Est. Return
VE
Vega Energy New York $75.5M AUM 15.36% 1-Year Est. Return
GFWEV
G.F.W. Energy VIII Irving, Texas $76.3M AUM 11.41% 1-Year Est. Return

FT Options's Q3 2017 Portfolio in Review

As of Q3 2017, FT Options held 297 positions worth $66.4M, up 14% from $58.1M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

FT Options deployed $122M of net new capital in Q3 2017, opening 108 new positions and adding to 49 existing holdings. Its largest new stake was Incyte: 27,887 shares worth $3.26M.

By sector, the portfolio is most concentrated in Healthcare at 42% of assets, up from 38% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.

On the sell side, the largest reduction was General Mills, an estimated $2.52M trimmed.

  • FT Options's largest Q3 2017 buy was Incyte: 27,887 shares worth $3.26M.
  • FT Options added most to Sio Gene Therapies Inc. Common Stock in Q3 2017, an estimated $1.37M increase.
  • FT Options's biggest Q3 2017 reduction was General Mills, cutting an estimated $2.52M.
  • FT Options fully exited Portola Pharmaceuticals, Inc. in Q3 2017, selling an estimated $2.31M.
  • FT Options's ten largest holdings make up 32% of its $66.4M portfolio in Q3 2017.
  • FT Options opened 108 new positions and closed 72 in Q3 2017.
  • FT Options's portfolio value rose 14% quarter-over-quarter to $66.4M.

Based on FT Options's 13F filing for Q3 2017, filed 13 Nov 2017.